General Info

Catalyst Pharmaceutical Partners is a specialty pharmaceutical company that is focused on the development and commercialization of prescription drugs for the treatment of addiction. The company undertakes research and development activities in the area of developing the molecule vigabatrin, which is used in the treatment for addiction to cocaine, amphetamines and other addictive substances. Its product candidate based on vigabatrin is CPP-109, which has been granted fast-track status by the Food and Drug Administration for the treatment of cocaine addiction. The company has an on-site laboratory and a staff of trained professionals. It has also conducted human clinical trials of CPP-109. The company is located in Coral Gables, Fla.